-
Broadening the Landscape for Treatment Recommendations in the Management of Axial Spondyloarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Wilson Bautista-Molano
-
Pursuing Gender Equity in Rheumatology: Thinking Beyond Gender Representation to Assess Gender Equality. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Laura Ross,Stephanie Bond,Jessica A Day
-
Association of Past Smoking Status With Gout in Māori People in Aotearoa New Zealand. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Niamh C Fanning,John F Pearson,Nicola Dalbeth,Huti Watson,Tony R Merriman,Lisa K Stamp
OBJECTIVE Evidence for an association of smoking with gout is conflicting. We assessed associations of current and past smoking with gout in an Aotearoa New Zealand (NZ) population. METHODS Multivariable logistic regression analysis was performed on cross-sectional data from participants of NZ Māori (from 2 studies: Genetics of Gout in Aotearoa [GGA] study of 293 participants with gout and 431 without;
-
Patient profiles in randomised controlled trials versus a real-world study, in psoriatic arthritis: scoping review and meta-analysis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Gelsomina Alle,Clementina Lopez-Medina,Stefan Siebert,Frédéric Lavie,Wim Noel,Josef S Smolen,Laure Gossec
OBJECTIVE Patients with psoriatic arthritis (PsA) in randomised controlled trials (RCTs) may not reflect patients in clinical practice. The objective was to perform a meta-analysis of PsA patients' characteristics in RCTs of biologic disease-modifying antirheumatic drugs (bDMARDs), and to compare them to patient profiles in a real-world study. METHODS Data sources: (a) Scoping literature review of
-
Tocilizumab for Giant Cell Arteritis: Clinical Outcomes Following Relapses and Tocilizumab Discontinuation Due to Adverse Events. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Fumika N Nagase,Sho Fukui,Naoho Takizawa,Toshihiro Yamaguchi,Nobuhiro Oda,Hajime Inokuchi,Takanori Ito,Mitsuru Watanabe,Masei Suda,Yochiro Haji,Yasuhiro Suyama,Ryo Rokutanda,Masahiro Minoda,Atsushi Nomura,Eishi Uechi,Hiromichi Tamaki
OBJECTIVE Tocilizumab (TCZ) is effective for giant cell arteritis (GCA). However, little is known regarding treatment modification and clinical outcomes after unfavorable events, such as GCA relapses or TCZ discontinuation due to adverse events (AEs). METHODS This multicenter retrospective study included GCA patients who initiated TCZ from 2008 to 2021 at five Japanese hospitals. GCA relapses and TCZ-related
-
Cardiovascular Health and Adverse Pregnancy Outcomes in Autoimmune Rheumatic Diseases. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Vijaya Prasanna Parimi,Vinod Ravindran
-
The evaluation of myocarditis in patients with Still's disease; clinical findings from the multicentre international AIDA Network Still's Disease Registry. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Piero Ruscitti,Ilenia Di Cola,Antonio Vitale,Valeria Caggiano,Pierpaolo Palumbo,Ernesto Di Cesare,Jiram Torres-Ruiz,Guillermo Arturo Guaracha-Basañez,Eduardo Martín-Nares,Francesco Ciccia,Daniela Iacono,Flavia Riccio,Maria Cristina Maggio,Samar Tharwat,Soad Hashad,Donato Rigante,Augusta Ortolan,Henrique A Mayrink Giardini,Isabele Parente de Brito Antonelli,Rafael Alves Cordeiro,Roberto Giacomelli,Luca
OBJECTIVE To evaluate the cardiac involvement in patients with Still's disease with a focus on myocarditis included in the multicenter AIDA (AutoInflammatory Disease Alliance) network Still's disease registry. To exploit the predictive factors for myocarditis in deriving a clinical risk patient profile for this severe manifestation. METHODS A multicenter observational study was built up assessing consecutive
-
Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis) Commencing Late in Life. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Mark C Hwang,Karim Doughem,MinJae Lee,Lianne S Gensler,Mariko L Ishimori,Michael M Ward,Matthew A Brown,Amirali Tahanan,Michael H Weisman,Mohammad H Rahbar,John D Reveille
-
Large Language Models in Rheumatologic Diagnosis: A Multimodal Performance Analysis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Mahmud Omar,Reem Agbareia,Eyal Klang,Mohammad E Naffaa
-
Disparities in time to diagnosis of Radiographic Axial Spondyloarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-04 Renato Ferrandiz-Espadin,Gabriela Rabasa,Sarah Gasman,Brooke McGinley,Rachael Stovall,S Reza Jafarzadeh,Jean W Liew,Maureen Dubreuil
OBJECTIVE Radiographic axial spondyloarthritis (r-axSpA) has a 7-year average diagnostic delay. While the impact of sex or gender on time to diagnosis has been evaluated, the role of social determinants of health remains understudied. We assessed whether time from initial clinical documentation of r-axSpA symptoms to r-axSpA diagnosis (diagnostic delay) varies based on sex, race, ethnicity, or the
-
Infected Tumoral Calcinosis Associated With Rheumatoid Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Eri Sugawara,Keita Ninagawa,Kazuaki Katsumata
Tumoral calcinosis (TC) is a syndrome of unknown etiology characterized by calcium salt deposition in soft tissues.1 A case of infected TC with rheumatoid arthritis (RA) is described.
-
Obese Patients With Polymyalgia Rheumatica Experience More Pain And Disability At Disease Onset And Require Higher Doses Of Glucocorticoids. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Marco A Cimmino,Cynthia S Crowson,Bhaskar Dasgupta,Michael Schirmer,Christian Dejaco,Carlo Salvarani,Eric L Matteson,Dario Camellino
OBJECTIVE polymyalgia rheumatica (PMR) is an inflammatory disorder of the elderly characterized by girdle pain and stiffness. Obesity has an influence on disease activity and outcome in rheumatic diseases like osteoarthritis and rheumatoid arthritis, but its relationship to the severity and outcome of PMR is unknown. METHODS In a post-hoc analysis, 83 patients with recent-onset PMR were studied over
-
Hydrocephalus-Related Dementia in Paget Disease of the Skull. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 João Daniel Ferreira Carvalho,José Carlos Romeu
Paget disease of bone (PDB) is a chronic skeletal disorder caused by abnormal bone remodeling. Although neurological complications are uncommon, they may arise in advanced cases, particularly with skull involvement.
-
The Lived Experiences of Older Adults with Systemic Lupus Erythematosus: Patient Perspectives. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Sarah B Lieber,Sarah R Young,Yvonne Shea,Sarah P Gottesman,Robyn Lipschultz,Dongmei Sun,M Carrington Reid,Lisa A Mandl,Iris Navarro-Millán
OBJECTIVE Little is known about perceptions of aging among individuals living with systemic lupus erythematosus (SLE). Gaining this knowledge could help to identify targets for future behavioral interventions aimed at successful aging with SLE. This qualitative study sought to elicit the lived experiences, and essence, of aging from older adults with SLE. METHODS We conducted semi-structured interviews
-
Ringing in the Patient Voice: Measuring Patients' Lived Experience of Dermatomyositis Symptoms. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Kaveh Ardalan,Lisa G Rider
The development and validation of measures of disease activity, damage, and health-related quality of life (HRQOL) over the past 30 years has been fundamental in advancing research and care for patients with adult and juvenile idiopathic inflammatory myopathies (IIMs).1 These efforts have resulted in the development of core set measures of disease activity and damage for myositis, and the American
-
Mucosa-Associated Lymphoid Tissue Lymphoma as a Rare Mimicker of Relapsing Polychondritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Norihisa Tada,Nao Oguro,Nobuyuki Yajima
Mucosa-associated lymphoid tissue (MALT) lymphoma is a low-grade B cell extranodal lymphoma characterized by clonal marginal zone lymphocyte proliferation. We report a case of MALT lymphoma with a relapsing polychondritis (RP)-like phenotype, manifesting as rapidly progressive tracheal stenosis requiring tracheotomy.
-
A Stratification Approach Based on Salivary Gland Ultrasonography for Assessing Secretory Function in Sjögren's Disease. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Wenke Huang,Shaoyun Hao,Zhiming Ouyang,Liqin Peng,Xinghuan Chen,Wenjing Yang,Wenjing Zhong,Junsheng Chen,Lie Dai,Yingqian Mo
OBJECTIVE Our aim was to develop an ultrasonographic scoring model for staging hypofunction of salivary gland (SG) in patients suffering from Sjögren's disease (SjD). METHODS The assessment of SG secretory hypofunction was conducted by measuring whole salivary flows. B-mode ultrasonography was performed bilaterally on the parotid and submandibular glands to evaluate the Gland score and OMERACT score
-
Incidence of Pneumocystis jirovecii Pneumonia and Prophylaxis-Associated Adverse Events Among Patients with Systemic Lupus Erythematosus. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Yiran Jiang,Alí Duarte-García,Michael Putman,David Gazeley
OBJECTIVE Pneumocystis jirovecii Pneumonia (PJP) is an opportunistic infection that may affect patients with systemic lupus erythematosus (SLE). The objective of this project was to describe the incidence of PJP among patients with SLE. METHODS A retrospective cohort analysis of the TriNetX database. Included patients had ≥2 ICD9- CM/ICD10-CM codes for SLE separated by at least 30 days and were new
-
Changes at Presentation in Patients With Early Rheumatoid Arthritis: A 24-Year Study of the Early Undifferentiated Polyarthritis (EUPA) Cohort. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Nathalie Carrier,Sophie Roux,Ariel Masetto,Artur J de Brum-Fernandes,Patrick Liang,Meryem Maoui,Gilles Boire
OBJECTIVE To analyze changes in baseline characteristics of patients with very early rheumatoid arthritis (RA) over 24 years in the Early Undifferentiated Polyarthritis (EUPA) cohort. METHODS Consecutive patients with recent-onset polyarthritis fulfilling RA classification criteria recruited in EUPA were assessed at baseline. Three successive periods were defined: (1) prior to the general availability
-
When to Schedule Your Next COVID-19 Vaccine. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Hinpetch Daungsupawong,Viroj Wiwanitkit
-
Prologue: Spondyloarthritis Unmet Research Needs Conference IV. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-24 Robert A Colbert,Ellen Carroll,Maureen Dubreuil,Lianne S Gensler,Nigil Haroon,Richard Howard,Alexis R Ogdie,Cassie Shafer,Pamela F Weiss,Kristine A Kuhn
The Spondylitis Association of America (SAA) and the National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS) convened a conference on the campus of the National Institutes of Health (NIH) on September 28 and 29, 2023, to identify unmet needs in spondyloarthritis (SpA) research. The conference featured presentations by experts in areas of disease endotypes, pain, innovative imaging
-
Are There Disease Endotypes in Axial Spondyloarthritis and How Would We Define Them? J. Rheumatol. (IF 3.6) Pub Date : 2024-10-24 Kevin D Deane,Laura T Donlin,Christopher T Ritchlin,Kristine A Kuhn
Is axial spondyloarthritis (axSpA) one disease or does it comprise multiple types? If the latter, how do we define those types-through clinical or imaging features, HLA-B27 status, or by other immunologic features? Data comparing disease outcomes for individuals with nonradiographic vs radiographic axSpA, or for male vs female patients, demonstrate distinctions. So then, how should we define endotypes
-
Enhancing Equity in Clinical Research: A Multifaceted Proposal for Spondyloarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-24 Maureen Dubreuil,Elizabeth D Ferucci,Hani El-Gabalawy,Sarfaraz Hasni,Edith M Williams
Clinical research advances medical knowledge and improves healthcare outcomes. However, disparities in research participation hinder progress. The Unmet Research Needs in Spondyloarthritis Conference IV highlighted critical insights and strategies to enhance equity in clinical research. Talks focused on engaging underrepresented communities and addressing disparities in rheumatic diseases, particularly
-
Unmet Needs in Spondyloarthritis: Pathogenesis, Clinical Trial Design, and Nonpharmacologic Therapy. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-24 Laura C Coates,Georg Schett,Chenchen Wang,Pamela F Weiss
A program focused on pathogenesis, clinical trial design, and nonpharmacologic mind-body therapy for of spondyloarthritis (SpA) was presented at the Spondylitis Association of America Unmet Needs Conference IV. SpA pathogenesis is incompletely understood but involves a complex set of drivers, including genetics, biomechanical stress, and microbial factors. Affected tissues may include axial and peripheral
-
Unmet Needs in Spondyloarthritis: Understanding and Managing Chronic Pain. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-24 Yvonne C Lee,Anne-Marie Malfait,Alexis R Ogdie
Among patients with axial spondyloarthritis (axSpA), persistent pain remains a critical unmet need. In this review, we discuss the prevalence of chronic pain and fibromyalgia in patients with axSpA and examine the existing knowledge on the pathophysiology of chronic pain in SpA, osteoarthritis, and rheumatoid arthritis. Finally, we discuss the specific unmet needs that must be addressed to improve
-
Unmet Needs in Spondyloarthritis: Imaging in Axial Spondyloarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-24 Lianne S Gensler,Lennart Jans,Sharmila Majumdar,Denis Poddubnyy
Imaging biomarkers in axial spondyloarthritis (axSpA) are currently the most specific biomarkers for the diagnosis of this condition. Despite advances in imaging, from plain radiographs-which detect only damage-to magnetic resonance imaging (MRI)-which identifies disease activity and structural change-there are still many challenges that remain. Imaging in sacroiliitis is characterized by active and
-
Disability Related to the Upper Extremities in Early Rheumatoid Arthritis-Long-Term Course and Disease Variable Impact: A Cohort Study. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-15 Maria Rydholm,Sofia Hagel,Lennart T H Jacobsson,Carl Turesson
OBJECTIVE To investigate the course of disability related to the upper extremities (UEs) in early rheumatoid arthritis (RA), and to assess correlations between such disability and clinical variables, including grip force. METHODS In an inception cohort of patients with early RA (diagnosed 1995-2005, N = 222, follow-up 10 yrs), disability of the UEs was assessed using a subscore of the Health Assessment
-
Trends in Anxiety and Depression Among Individuals With Rheumatoid Arthritis: A Population-Based Study. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Rachel E Giblon,Sara J Achenbach,Elena Myasoedova,John M Davis,Vanessa L Kronzer,William V Bobo,Cynthia S Crowson
OBJECTIVE To investigate trends in depression and anxiety over 3 decades among individuals with rheumatoid arthritis (RA). METHODS Patients with incident RA (age ≥ 18 years, meeting 1987 American College of Rheumatology criteria between 1985 and 2014) were identified using the Rochester Epidemiology Project. Individuals with RA were matched 1:1 with non-RA comparators on age, sex, and calendar year
-
Epidemiological characteristics of patients with juvenile dermatomyositis in China: a multicenter study. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-15 Xuanyi Liu,Junmei Zhang,Hui Xu,Weiying Kuang,Jianghong Deng,Xiaohua Tan,Chao Li,Shipeng Li,Yuan Xue,Guoshuang Feng,Caifeng Li,
OBJECTIVE Juvenile dermatomyositis (JDM) is a rare but chronic autoimmune disease with systemic nonsuppurative inflammation. Many studies have focused on the clinical characteristics and therapy of JDM. A few studies have reported the epidemiological characteristics and social burden of JDM patients abroad, but there has been no study in China. METHODS This study was based on the FUTang Updating medical
-
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-15 Victoria Navarro-Compán,Martin Rudwaleit,Maureen Dubreuil,Marina Magrey,Helena Marzo-Ortega,Philip J Mease,Jessica A Walsh,Maxime Dougados,Christine de la Loge,Carmen Fleurinck,Ute Massow,Thomas Vaux,Vanessa Taieb,Atul Deodhar
OBJECTIVE To assess the effect of bimekizumab on pain, morning stiffness, and fatigue in patients with nonradiographic and radiographic axial spondyloarthritis (axSpA) in the phase III BE MOBILE studies (ClinicalTrials.gov: NCT03928704 and NCT03928743). METHODS Patients were randomized to bimekizumab 160 mg or placebo every 4 weeks; and all patients received bimekizumab from week 16. Patients reported
-
The Rheumatologist as the Agent of Change: Utility of Guidelines in the Management of Gout. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-15 Puja P Khanna
The development and implementation of guidelines are intended to improve the quality of care by translating current evidence into clinical practice. However, the publication and dissemination of guidelines do not intuitively result in their use. Evidence indicates that structured implementation can improve guideline adherence.1.
-
Infections in Vasculitis: Can We Create an Epidemic of Change? J. Rheumatol. (IF 3.6) Pub Date : 2024-10-15 Gretchen Santana Cepero,John E McKinnon,Kathleen Maksimowicz-McKinnon
In the article entitled "Prevalence, Predictors, and Prognosis of Serious Infections in Takayasu Arteritis: A Cohort Study" by Misra and colleagues in this issue of The Journal of Rheumatology, the authors examine the incidence of serious infections in a Takayasu arteritis (TA) patient cohort; analyze associated demographic, clinical, angiographic, and treatment-related factors; and evaluate their
-
Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-15 Sofia Exarchou,Daniela Di Giuseppe,Eva Klingberg,Valgerdur Sigurdardottir,Sara Wedrén,Ulf Lindström,Carl Turesson,Lennart T H Jacobsson,Johan Askling,Johan K Wallman
OBJECTIVE Prior incidence estimates of psoriatic arthritis (PsA) vary considerably. We aimed to assess the annual incidence of clinically diagnosed PsA among adults in Sweden in 2014-2016, overall and stratified by age/sex/education/geography, and to investigate potential time trends in incidence in 2006-2018. Use of disease-modifying antirheumatic drugs (DMARDs) during the 2 years after diagnosis
-
A Real-World Analysis of Weather Variation on Disease Activity and Patient-Reported Outcomes in Psoriatic Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-15 Maxine Joly-Chevrier,Louis Coupal,Loïc Choquette Sauvageau,Mohammad Movahedi,Denis Choquette
OBJECTIVE Patients with inflammatory articular diseases, such as psoriatic arthritis (PsA), report weather changes in their symptoms. Our objective was to investigate the correlation between weather variation, disease activity (DA), and patient-reported outcomes (PROs) in patients with PsA. METHODS Hourly measurements of temperature, relative humidity, and pressure were obtained from 2015 to 2020 in
-
Effect of Online Training on the Reliability of Assessing Sacroiliac Joint Radiographs in Axial Spondyloarthritis: A Randomized, Controlled Study. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-15 Anna E F Hadsbjerg,Mikkel Østergaard,Joel Paschke,Raphael Micheroli,Susanne J Pedersen,Adrian Ciurea,Michael J Nissen,Kristyna Bubova,Stephanie Wichuk,Manouk de Hooge,Simon Krabbe,Ashish J Mathew,Monika Gregová,Marie Wetterslev,Karel Gorican,Karlo Pintaric,Ziga Snoj,Burkhard Möller,Alexander Bernatschek,Maurice Donzallaz,Robert G Lambert,Walter P Maksymowych
OBJECTIVE Radiographic assessment of sacroiliac joints (SIJs) according to the modified New York (mNY) criteria is key in the classification of axial spondyloarthritis but has moderate interreader agreement. We aimed to investigate the improvements of the reliability in scoring SIJ radiographs after applying an online real-time iterative calibration (RETIC) module, in addition to a slideshow and video
-
Stop Interfering! A Reflection on the Intrusive and Elusive Nature of Pain in Juvenile Idiopathic Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Tara R McGrath,Dax G Rumsey
The face of juvenile idiopathic arthritis (JIA) management has transformed over the last 30 years, with advancements that have dramatically improved outcomes and overall prognosis. Yet, despite contemporary advances, including biologic therapies, pain in patients with JIA remains common.1.
-
Finding the Role of Anifrolumab in the New Paradigm of Systemic Lupus Erythematosus Treatment. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Romina Estefanía Nieto,Graciela S Alarcón,Laurent Arnaud,Guillermo Javier Pons-Estel
The article by Tani et al, "Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study,"1 evaluates the efficacy of anifrolumab (ANI) in patients with systemic lupus erythematosus (SLE) who failed to respond to other treatments, including biologics.There are many unmet needs in the treatment of SLE. Despite recent advances, remission and low disease activity (LDA) rates
-
The Significance of Intracellular Versus Extracellular Calcium Pyrophosphate Crystals in Diagnosing Calcium Pyrophosphate Crystal Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 David J Harris,Douglas H N White,Uri M Arad
OBJECTIVE Acute and chronic calcium pyrophosphate (CPP) crystal arthritis is characterized by the presence of synovial CPP crystals within a clinically inflamed joint. CPP crystals may be situated intracellularly or extracellularly; however, the clinical significance of their location remains understudied. The objective of this retrospective cohort study was to assess the relevance of the CPP crystal
-
Remission Is the Mission in Gout. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Till Uhlig
Remission is a concept that rheumatologists have accepted as an explicit goal for treatment of their patients with inflammatory disease. With its Latin origins (remittere, to send back), remission has been used as a noun with different meanings. According to the Oxford English Dictionary, one meaning is a cancellation of a debt, charge, or penalty.
-
Fetal Atrial Flutter: A Potential Rare Phenotype of Maternal SSA/SSB Antibody-Associated Fetal Cardiac Disease. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-01 Romeo Micu,Dan Boitor-Borza,Mihaela Cosmina Micu
Fetal atrial flutter (AF) is a reentrant tachyarrhythmia characterized by very fast, regular atrial and ventricular rates (400-500 bpm and 200-220 bpm, respectively). It occurs mainly in an anatomically normal heart and is usually treated with digoxin, which is often effective, with no further recurrence.1.
-
The 1st GRAPPA International Meeting on Psoriasis and Psoriatic Arthritis - 1º Encontro Internacional do GRAPPA sobre Psoríase e Artrite Psoriásica. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-01 Claudia Goldenstein-Schainberg,Dimitri Luz Felipe da Silva,Enrique R Soriano,Laura J Savage,Philip J Mease
The 1st GRAPPA International Meeting on Psoriasis and Psoriatic Arthritis - 1° Encontro Internacional do GRAPPA Sobre Psoríase e Artrite Psoriásica was held on August 18-19, 2023, in São Paulo, Brazil, and marked a turning point in the management of psoriasis (PsO) and psoriatic arthritis (PsA) in our country. This was an international collaboration, between Brazilian rheumatologists and dermatologists
-
An Atypical Presentation of Parvovirus B19 Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-01 Tia Solomon,Anne Powell,John Findeisen
It is well established that acute parvovirus B19 (B19V) infection in adults is associated with peripheral inflammatory arthritis.1 Joint involvement is usually symmetric and acute, most commonly involving the knees, feet, wrists, and small joints of the hands.2.
-
Gut Microbiomics of Sustained Knee Pain in Patients With Knee Osteoarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-01 Jingyi Huang,Ming Liu,Andrew Furey,Proton Rahman,Guangju Zhai
OBJECTIVE To examine whether gut microbes were associated with postsurgery-sustained knee pain in patients with knee osteoarthritis (OA) by a gut microbiomics approach. METHODS Patients receiving total knee replacement (TKR) because of primary knee OA were recruited. Sustained knee pain status at ≥ 1 year after TKR was defined by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
-
Assessing Competencies, Needs, and Satisfaction With the Transition From Pediatric to Adult Health Care in Rheumatology: Development and Validation of the Transition-KompAZ. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-01 Henriette Haney,Jens Klotsche,Martina Niewerth,Sandra Hansmann,Gabi Erbis,Christiane Reiser,Sebastian Jonas Saur,Paula Hoff,Eva Seipelt,Anna Maier,Susanne Schalm,Stefanie Tatsis,Ivan Foeldvari,Ina Kötter,Kirsten Minden
J Rheumatol 2024; doi: 10.3899/jrheum.2024-0097 There were incorrect footnotes in Table 2. All instances of footnote "a" in the Possible Score Range column should be an asterisk. The correct footnote should be, "Only participants with ≤ 1 missing or * additional answer category (ie, "does not currently apply to me") per domain are included for the sum score of the corresponding scale." We apologize
-
Incidence of Psoriatic Arthritis in a Primary Care Psoriasis Population in the United Kingdom. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Alex Rudge,Sarah T Brown,Myka Ransom,Philip S Helliwell,Jonathan Packham,William Tillett,Theresa Smith,Neil J McHugh,
OBJECTIVE To determine the annual incidence of psoriatic arthritis (PsA) in a United Kingdom primary care population with preexisting psoriasis (PsO) followed prospectively over 2 years after excluding baseline prevalence of existing disease. METHODS Total Burden of Psoriasis (TUDOR; ISRCTN registry: ISRCTN38877516) was a multicenter, prospective, 2-arm parallel-group cluster randomized controlled
-
Performance of the 2022 ACR/EULAR Classification Criteria in Comparison With the European Medicines Agency Algorithm in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Yuki Imai,Yuichiro Ota,Kotaro Matsumoto,Mitsuhiro Akiyama,Katsuya Suzuki,Yuko Kaneko
OBJECTIVE This study aimed to compare the 2022 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) classification criteria with the European Medicines Agency (EMA) algorithm for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). METHODS All consecutive, newly diagnosed patients with AAV according to the 2012 Chapel Hill Consensus Conference
-
Pain Interference in Juvenile Idiopathic Arthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Rachel L Randell,Bryce B Reeve,Elissa R Weitzman,Emily von Scheven,Christina K Zigler,Zhen Li,Courtney M Mann,Alexy Hernandez,Li Lin,Camila Reyes,Laura E Schanberg,
OBJECTIVE Despite treatment advances, pain remains a serious problem for many children with juvenile idiopathic arthritis (JIA). To better understand pain in children with JIA and identify potentially modifiable factors, this study evaluated Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Pain Interference (PI) and its relationships with other pain measures and demographic
-
Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries. J. Rheumatol. (IF 3.6) Pub Date : 2024-11-01 Sella Aarrestad Provan,Lotta Ljung,Eirik Klami Kristianslund,Brigitte Michelsen,Till Uhlig,Thorarinn Jonmundsson,Joe Sexton,Bjorn Gudbjornsson,Daniela Di Giuseppe,Merete Lund Hetland,Gudrun Bjork Reynisdottir,Bente Glintborg,Heikki Relas,Kalle Aaltonen,Tore Kristian Kvien,Johan Askling
OBJECTIVE Interstitial lung disease (ILD) is one of the most common pulmonary manifestations of rheumatoid arthritis (RA), but its prevalence has not been investigated in psoriatic arthritis (PsA). The role of methotrexate (MTX) in ILD development remains under debate. This study (1) compares the incidences of ILD in patients with RA or PsA initiating a first biologic disease-modifying antirheumatic
-
Connecting the Docs in Vasculitis Pregnancies. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-01 Arielle Mendel,Évelyne Vinet
Pregnancy is a time of emotional stress for many women, and women with systemic vasculitides face substantial additional challenges. Systemic vasculitides are rare rheumatic diseases characterized by inflammation in blood vessel walls, classified according to vessel size, histopathology, and clinical features.1.
-
Candidate Biomarkers for Response to Treatment in Psoriatic Disease. J. Rheumatol. (IF 3.6) Pub Date : 2024-10-01 Rachel Offenheim,Omar F Cruz-Correa,Darshini Ganatra,Dafna D Gladman
OBJECTIVE To determine whether biologic therapy alters serum C-X-C motif chemokine ligand 10 (CXCL10), matrix metalloproteinase 3 (MMP3), S100 calcium-binding protein A8 (S100A8), acid phosphatase 5 (ACP5), and C-C motif chemokine ligand 2 (CCL2) levels in patients with psoriatic arthritis (PsA) and cutaneous psoriasis without arthritis (PsC), and whether baseline levels of these proteins predict response
-
Renal-Limited IgG4-Related Disease Presenting as Hypodense Lesions Found During Surveillance Imaging in a Patient With High-Grade Urothelial Cell Carcinoma. J. Rheumatol. (IF 3.6) Pub Date : 2024-09-01 Nehaal H Ahmed,Lihong Bu,Matthew J Koster
Renal lesions as the initial presentation of IgG4-related disease (IgG4-RD) and isolated IgG4-related kidney disease (IgG4-RKD) are rare.1,2A 65-year-old male with a history of high-grade urothelial cell carcinoma in remission was found to have multiple renal lesions on surveillance imaging (Figure 1A).
-
Necrotizing Sarcoid Granulomatosis in a Patient With Systemic Sclerosis. J. Rheumatol. (IF 3.6) Pub Date : 2024-09-01 Bernardo D'Onofrio,Egesta Lopci,Maria De Santis,Carlo Selmi
Systemic sclerosis (SSc) rarely overlaps with noninfective granulomatous conditions, such as sarcoidosis or pneumoconiosis.1A 73-year-old White man with anti-Scl70 positive SSc was evaluated for arthralgia, fever, and weight loss.
-
Clustering Methods in Rheumatic and Musculoskeletal Diseases Research: An Educational Guide to Best Research Practices. J. Rheumatol. (IF 3.6) Pub Date : 2024-09-01 Samantha Chin,Jamie E Collins
Clinical manifestations and disease progression often exhibit significant variability among patients with rheumatic diseases, complicating diagnosis and treatment strategies. A better understanding of disease heterogeneity may allow for personalized treatment strategies. Cluster analysis is a class of statistical methods that aims to identify subgroups or patterns within a dataset. Cluster analysis
-
Opioid Use and Healthcare Utilization in Adults With Psoriatic Arthritis and Ankylosing Spondylitis. J. Rheumatol. (IF 3.6) Pub Date : 2024-08-15 Jean W Liew, Sofia Pedro, Kaleb Michaud, Alexis Ogdie
Opioid use among individuals with spondyloarthritis is common; however, data on whether these individuals have higher utilization of the healthcare system are lacking. We examined the association between opioid use and healthcare utilization and costs among patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS).
-
Decision Aid-Led Tapering of Biologic and Targeted Synthetic DMARDs in Rheumatoid Arthritis: A Qualitative Study. J. Rheumatol. (IF 3.6) Pub Date : 2024-08-15 Jungyeon Lee, Claire Barber, Michelle Jung, Elzbieta Kaminska, Nick Bansback, Dawn Richards, Laurie Proulx, Ann Rebutoc, Glen S Hazlewood
To explore the experiences and perspectives of patients and rheumatologists on decision aid-led tapering of advanced therapy in rheumatoid arthritis (RA).
-
Stressed Healthcare Systems: The Impact on the Care of Patients With Rheumatic Diseases. J. Rheumatol. (IF 3.6) Pub Date : 2024-08-15 Marina Scolnik
Healthcare systems worldwide face various challenges, including disparities in infrastructure, shortages in healthcare professionals, and inadequate funding.1,2 These challenges lead to issues such as suboptimal treatment, limited access to essential services, and difficulties in responding to health crises like the coronavirus disease 2019 (COVID-19) pandemic.1.
-
Absence of Glucocorticoids Concomitant With Avacopan and Subsequent Liver Injury in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. J. Rheumatol. (IF 3.6) Pub Date : 2024-08-15 Tomohisa Uchida, Shoichi Fukui, Naoki Iwamoto, Ayaka Umetsu, Momoko Okamoto, Keita Fujikawa, Akinari Mizokami, Takuya Tomokawa, Kazusato Hara, Yoshiro Horai, Atsushi Kawakami
Avacopan, a C5a receptor (C5aR) inhibitor, has emerged as a novel treatment for antineutrophil cytoplasmic antibody-associated vasculitis (AAV), providing an alternative to glucocorticoids (GCs).1 Despite its promising potential, severe liver dysfunction associated with avacopan has been reported in Japan.2,3.
-
Evidence That Good Life With Osteoarthritis in Denmark (GLA:D), an Exercise and Education Program, Is Beneficial for Osteoarthritis. J. Rheumatol. (IF 3.6) Pub Date : 2024-08-15 Grace H Lo, Jeffrey B Driban
In this issue of The Journal of Rheumatology, the article by King et al describes a registry-based cohort study of the Good Life With Osteoarthritis in Denmark (GLA:D) 8-week education and exercise program.1 Rather than focusing on knee pain, the authors examined change in self-reported difficulty walking, a primary reason people with knee osteoarthritis (OA) seek care, and assessed patient factors
-
Vanishing Abdominal Aorta. J. Rheumatol. (IF 3.6) Pub Date : 2024-08-15 Kenji Yamada, Ryo Hazue, Ryo Rokutanda
Fewer than 1% of Takayasu arteritis (TA) cases are diagnosed in individuals over 60 years old.1 Early-stage TA generally presents with nonspecific systemic inflammatory symptoms, which can progress to the chronic, fibrotic occlusive phase,2 although there is significant heterogeneity in disease activity.3.
-
Acute Severe Inflammatory Lumbar Spinal Pain Induced by Calcium Pyrophosphate Crystals: Computed Tomography Is Everything. J. Rheumatol. (IF 3.6) Pub Date : 2024-08-15 Abuelmagd Abdalla, Colm Byrne, Eoin Kavanagh, Geraldine M McCarthy
Acute back pain with neurological symptoms is a medical emergency. Here we report a case of severe degenerative spine disease with raised inflammatory markers due to an atypical cause.